close
read more
Our company
Governance
Global presence
Key figures
Story
Vocation, vision and values
Culture
Financial Results
Servier Institute
Our healthcare offering
Servier medicines
Generic medicines
e-Health solutions
Our areas of expertise
Research & Development
Therapeutic areas
Development portfolio
Clinical trials
Regulatory affairs
Pharmacovigilance
Servier Paris-Saclay Research Institute
Medical promotion
Industry
Industrial quality
Production
Supply Chain
CDMO Services
Medical Affairs
Business development & licensing
Our commitments
Patient
Ethics
Compliance policy
CSR approach
Fight against counterfeiting
Supplier relationship
Servier endowment fund
Newsroom
News
Press release
Insight
Corporate publishing
Medical publishing
FR
MEDIATOR INFORMATION
NEWS
ROOM
News
Press release
Insight
Corporate publishing
Medical publishing
Publication of the 2019 CSR Report
29 / 07 / 2020
News
“Coalition Innovation Santé”: Servier supports Chronolife
23 / 07 / 2020
News
Global warming: the Servier strategy validated by the SBTi
07 / 07 / 2020
News
New collaboration between Servier and the Autonomous University of Barcelona in Parkinson’s disease
30 / 06 / 2020
News
“Coalition Innovation Santé”: Servier supports the start-up myCharlotte
22 / 06 / 2020
News
One year anniversary of Servier Paris-Saclay Research Institute’s foundation stone laying
19 / 06 / 2020
News
“Coalition Innovation Santé”: Servier supports the start-up Cureety
15 / 06 / 2020
News
Servier Turkey receives the Best Employer certification
12 / 06 / 2020
News
Counterfeit medicines: A global threat heightened by COVID-19
10 / 06 / 2020
News
Servier completes the acquisition of Symphogen
04 / 06 / 2020
News
Clinical Trials: Servier adapts to ensure continuity
20 / 05 / 2020
News
Servier is more committed than ever in the fight against hypertension!
17 / 05 / 2020
News